Racial differences in prostate-specific antigen-based prostate cancer screening: state-by-state and region-by-region analyses.

Document Type


Publication Date



Urology, CORE

Journal Title

Urologic oncology.

MeSH Headings

Aged, Continental Population Groups, Early Detection of Cancer, Humans, Male, Middle Aged, Prostate-Specific Antigen, Prostatic Neoplasms


OBJECTIVE: Black men are more prone to harbor prostate cancer. They are more likely to succumb to this tumor than their White counterparts and may benefit from early detection and treatment. In this study, we assess the nationwide and regional disparity in prostate-specific antigen (PSA) screening for prostate cancer between Black men and non-Hispanic Whites (NHWs).

METHODS: A total of 247,079 (weighted 55,185,102) men, aged 40 to 99 years, who responded to the 2012 and 2014 behavioral risk factor surveillance system surveys were used for our analysis. End points consisted of self-reported PSA screening and self-reported nonrecommended PSA screening within 12 months of the interview. The latter was defined as screening in men with

RESULTS: Prevalence of PSA screening was 30.7% in NHWs vs. 28.1% in Blacks (P

CONCLUSION: Our study demonstrates that on a regional-level (and state-level), there are significant racial differences in overall and nonrecommended PSA screening across the United States. Further research is necessary to identify the reasons for the differences and help overcoming it.



First Page


Last Page